IE35937B1 - Local anaesthetic composition - Google Patents

Local anaesthetic composition

Info

Publication number
IE35937B1
IE35937B1 IE1611/71A IE161171A IE35937B1 IE 35937 B1 IE35937 B1 IE 35937B1 IE 1611/71 A IE1611/71 A IE 1611/71A IE 161171 A IE161171 A IE 161171A IE 35937 B1 IE35937 B1 IE 35937B1
Authority
IE
Ireland
Prior art keywords
local anaesthetic
anaesthetic composition
composition
local
anaesthetic
Prior art date
Application number
IE1611/71A
Other languages
English (en)
Other versions
IE35937L (en
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of IE35937L publication Critical patent/IE35937L/xx
Publication of IE35937B1 publication Critical patent/IE35937B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE1611/71A 1971-01-26 1971-12-20 Local anaesthetic composition IE35937B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (2)

Publication Number Publication Date
IE35937L IE35937L (en) 1972-07-26
IE35937B1 true IE35937B1 (en) 1976-07-07

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
IE1611/71A IE35937B1 (en) 1971-01-26 1971-12-20 Local anaesthetic composition
IE1610/71A IE35910B1 (en) 1971-01-26 1971-12-20 Pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE1610/71A IE35910B1 (en) 1971-01-26 1971-12-20 Pharmaceutical composition

Country Status (18)

Country Link
AT (2) AT310938B (enExample)
AU (1) AU465875B2 (enExample)
BE (2) BE776769A (enExample)
BR (2) BR7108429D0 (enExample)
CA (2) CA986012A (enExample)
DD (2) DD96144A5 (enExample)
DE (2) DE2163054C3 (enExample)
DK (2) DK130389B (enExample)
ES (2) ES398108A1 (enExample)
FR (2) FR2123277B1 (enExample)
GB (1) GB1370904A (enExample)
HU (2) HU162185B (enExample)
IE (2) IE35937B1 (enExample)
LU (1) LU64664A1 (enExample)
NL (2) NL7117401A (enExample)
NO (2) NO135891C (enExample)
SE (2) SE391286B (enExample)
ZA (2) ZA718326B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
WO1998051290A2 (en) * 1997-05-16 1998-11-19 Children's Medical Center Corporation Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
RU2277097C1 (ru) * 2004-12-27 2006-05-27 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Высокомеченный тритием дигидрохлорид [3h]сакситоксина
CN101563079B (zh) 2006-03-27 2012-12-05 威克斯药业有限公司 钠通道阻滞剂在制备治疗由于化疗而产生的神经病理性疼痛的药物中的用途
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
KR20210062693A (ko) 2013-03-15 2021-05-31 더 칠드런스 메디칼 센터 코포레이션 지속성 국소 마취용 네오삭시톡신 조합 제형

Also Published As

Publication number Publication date
BR7108428D0 (pt) 1973-06-14
DK131606B (da) 1975-08-11
DD96144A5 (enExample) 1973-03-12
DE2163054B2 (de) 1978-06-01
BE776768A (fr) 1972-06-16
HU162185B (enExample) 1973-01-29
AT310938B (de) 1973-10-25
AU3710171A (en) 1973-06-28
IE35910L (en) 1972-07-26
ES398109A1 (es) 1975-03-16
ZA718326B (en) 1972-09-27
SE391127B (sv) 1977-02-07
DK131606C (da) 1976-01-12
DD96400A5 (enExample) 1973-03-20
FR2123277B1 (enExample) 1975-06-13
NO135892C (no) 1978-05-16
DE2163054A1 (de) 1974-05-02
BR7108429D0 (pt) 1973-06-14
DK130389C (enExample) 1975-07-14
DE2163055A1 (de) 1972-10-12
HU162347B (enExample) 1973-02-28
NO135892B (enExample) 1977-03-14
IE35937L (en) 1972-07-26
IE35910B1 (en) 1976-06-23
FR2123277A1 (enExample) 1972-09-08
BE776769A (fr) 1972-06-16
AU3710071A (en) 1973-06-28
NL7117401A (enExample) 1972-07-28
DK130389B (da) 1975-02-17
FR2123278A1 (enExample) 1972-09-08
NO135891C (no) 1978-05-16
ZA718327B (en) 1972-09-27
NL7117404A (enExample) 1972-07-28
GB1370904A (en) 1974-10-16
FR2123278B1 (enExample) 1975-08-01
ES398108A1 (es) 1975-03-01
NO135891B (enExample) 1977-03-14
CA986012A (en) 1976-03-23
AU465875B2 (en) 1975-10-09
SE391286B (sv) 1977-02-14
DE2163054C3 (de) 1979-02-01
AT310939B (de) 1973-10-25
LU64664A1 (enExample) 1972-08-23
CA983850A (en) 1976-02-17

Similar Documents

Publication Publication Date Title
IE36891L (en) Coronary-dilating composition
AU5119173A (en) Composition
ZA727741B (en) Thermofomable compositions
HK57478A (en) Photopolymerisable composition
GB1372932A (en) Anti-caries compositions
PH10909A (en) Esterocyclic compounds and compositions thereof
ZA721353B (en) Polyamide-diazo resin composition
ZA724552B (en) Antiseborrhoeic compositions
ZA721446B (en) Substituted 3-benzylpyridines
ZA723241B (en) Plaster composition
GB1393014A (en) Polyurethane-tar compositions
IE35937L (en) Local anaesthetic composition
ZA721359B (en) Substituted thiadiazolidine-diones
IL39336A0 (en) Substituted 2-anilinobenzoxazoles
ZA722089B (en) Substituted chlorocarbonylureas
JPS5494024A (en) Photosensitive composition
GB1391562A (en) Resinous composition
GB1370905A (en) Local anaesthetic composition
GB1367202A (en) Reflex-reflecting compositions
YU282572A (en) Kuciste i poklopac kucista
IL39333A0 (en) Substituted benzimidazolecarbamates
ZA72714B (en) Substituted phenylthiocarbamates
ZA717795B (en) Anesthetic
CY755A (en) Therapeutic composition
ZA72669B (en) Substituted 1-phenyl-6-azacytosines